Lantern Pharma Inc. Amortization of Debt Issuance Costs
Lantern Pharma Inc. (LTRN) reported Amortization of Debt Issuance Costs of $512.00 thousand for the 1-month period ending 2026-05-31, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-14
- Lantern Pharma Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was $30.60K.
- Lantern Pharma Inc. amortization of debt issuance costs for fiscal 2025 was $61.32K.
| Period end | Amortization of Debt Issuance Costs 1 month | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2026-05-31 | $512.00K 10-Q · filed 2026-08-14 | |||
| 2025-12-31 | $30.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $61.32K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | $30.72K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |